Sharda Cropchem (SHARDACROP) Q4 24/25 earnings summary

Executive summary

• FY 2025 revenue grew 37% year-over-year to INR 4,320 crore, with Q4 revenue up 39% and volume growth over 50%, driven by strong contributions from Europe, Latin America, and NAFTA regions.

• Agrochemical segment contributed 87% of total revenues, with significant growth in herbicides, insecticides, and fungicides.

• PAT surged to Rs. 304 crores, up from Rs. 32 crores in FY24, reflecting robust operational performance.

• The company holds 2,964 product registrations globally, with 1,014 applications in process.

• Board approved audited consolidated and standalone financial results for FY ended March 31, 2025, with no audit qualifications from statutory auditors.

Financial highlights

• FY 2025 revenue: Rs. 4,320 crores (+37% YoY); Q4 FY25 revenue: Rs. 1,829 crores (+39% YoY).

• FY 2025 EBITDA: Rs. 682 crores (+114% YoY); Q4 FY25 EBITDA: Rs. 352 crores (+16% YoY).

• FY 2025 PAT: Rs. 304 crores (+854% YoY); Q4 FY25 PAT: Rs. 204 crores (+42% YoY).

• Gross margin for FY25: 29.9% (up 400 bps); EBITDA margin: 15.8%.

• Earnings per share for FY25: Rs. 33.74 (up from Rs. 3.53 in FY24).

Outlook and guidance

• Targeting over 15% top-line growth in FY 2026, with gross margins expected to improve as prices rise.

• EBITDA margin guidance maintained at 15%-18% for FY 2026.

• Price and volume growth expected at 10%-15% for FY 2026, with gradual price improvement anticipated from Q1.

• Board notes the seasonal nature of the agrochemicals segment, with performance impacted by cropping patterns and weather globally.

• Continued focus on expanding global presence, operational efficiencies, and margin improvements.